Synthesis and Preliminary Evaluation of an In Vivo Stable 131 I‐Labeled Deuterated Tropane for Mapping Dopamine Transporter
Journal of Labelled Compounds and Radiopharmaceuticals · 2025
DOI: 10.1002/jlcr.4147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2025. Verfasst von Jiaojiao Zuo und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Dopamine Plasma Membrane Transport Proteins, Iodine Radioisotopes, Tropanes, Deuterium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Youth Fund of the National Natural Science Foundation of China, Jiangsu Commission of Health.
Abstract (Originalsprache)
Dopamine transporter (DAT) is closely associated with neurodegenerative diseases such as Parkinson's disease (PD). To develop an in vivo stable radioligand targeting DAT, we synthesized a novel iodine‐131‐labeled tropane analog [ 131 I] 1 with deuteration on both the N ‐fluoropropyl and 2 β ‐carbomethoxy positions of the tropane scaffold and then biologically compared with the previously reported analog [ 131 I]FP‐CIT‐d 6 with deuteration only on the N ‐fluoropropyl group. The radioligand [ 131 I] 1 was obtained via a radioiodine‐destannylation reaction with a radiochemical yield of ~95%, a radiochemical purity of > 99% and a molar activity of 12.72 GBq/μmol. [ 131 I] 1 exhibited a high in vitro binding affinity for DAT with an IC 50 value of 2.2 nM. Metabolic stability studies demonstrated that [ 131 I] 1 displayed superior in vivo stability compared with [ 131 I]FP‐CIT‐d 6 . Biodistribution studies revealed that [ 131 I] 1 had better DAT affinity, specificity, and a higher target‐to‐background ratio than [ 131 I]FP‐CIT‐d 6 . Ex vivo autoradiography and blocking experiments validated the selective and reversible binding of [ 131 I] 1 to DAT and superiority to [ 131 I]FP‐CIT‐d 6 . These preliminary results suggest that deuterated radioligand [ 131 I] 1 , with enhanced in vivo stability and higher target‐to‐background ratio, is a promising DAT probe, warranting the development and application of 123 I‐labeled counterpart ([ 123 I] 1 ) for SPECT imaging in DAT‐related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science, Inner Mongolia Medical University, Hohhot, China.
- NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China.
- Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing, China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, China.
ORCID-Profile: Yi Fang, Zhengping Chen
Förderung
- National Natural Science Foundation of China
- Youth Fund of the National Natural Science Foundation of China
- Jiangsu Commission of Health
- Jiangsu Province Capability Improvement Project through Science, Technology and Education
Zitieren
APA
Zuo, J., Kang, J., Hong, J., Li, J., Fang, Y., Liu, C., Xie, M., & Chen, Z. (2025). Synthesis and Preliminary Evaluation of an In Vivo Stable 131 I‐Labeled Deuterated Tropane for Mapping Dopamine Transporter. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4147
Vancouver
Zuo J, Kang J, Hong J, Li J, Fang Y, Liu C, et al. Synthesis and Preliminary Evaluation of an In Vivo Stable 131 I‐Labeled Deuterated Tropane for Mapping Dopamine Transporter. Journal of Labelled Compounds and Radiopharmaceuticals. 2025. doi:10.1002/jlcr.4147
BibTeX
@article{Zuo2025,
author = {Zuo, Jiaojiao and Kang, Jing and Hong, Jingjing and Li, Jingwen and Fang, Yi and Liu, Chunyi and Xie, Minhao and Chen, Zhengping},
title = {Synthesis and Preliminary Evaluation of an In Vivo Stable 131 I‐Labeled Deuterated Tropane for Mapping Dopamine Transporter},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2025},
doi = {10.1002/jlcr.4147}
}
EUVIMED